Biotransformation of curcumin through reduction and glucuronidation in mice - PubMed (original) (raw)
Affiliations
- PMID: 10101144
Biotransformation of curcumin through reduction and glucuronidation in mice
M H Pan et al. Drug Metab Dispos. 1999 Apr.
Abstract
Curcumin, the yellow pigment in turmeric and curry, has antioxidative and anticarcinogenic activities. In this study, we investigated the pharmacokinetic properties of curcumin in mice. After i.p. administration of curcumin (0.1 g/kg) to mice, about 2.25 microg/ml of curcumin appeared in the plasma in the first 15 min. One hour after administration, the levels of curcumin in the intestines, spleen, liver, and kidneys were 177.04, 26.06, 26.90, and 7.51 microg/g, respectively. Only traces (0.41 microg/g) were observed in the brain at 1 h. To clarify the nature of the metabolites of curcumin, the plasma was analyzed by reversed-phase HPLC, and two putative conjugates were observed. Treatment of the plasma with beta-glucuronidase resulted in a decrease in the concentrations of these two putative conjugates and the concomitant appearance of tetrahydrocurcumin (THC) and curcumin, respectively. To investigate the nature of these glucuronide conjugates in vivo, the plasma was analyzed by electrospray. The chemical structures of these metabolites, determined by mass spectrometry/mass spectrometry analysis, suggested that curcumin was first biotransformed to dihydrocurcumin and THC and that these compounds subsequently were converted to monoglucuronide conjugates. Because THC is one of the major metabolites of curcumin, we studied its stability at different pH values. THC was very stable in 0.1 M phosphate buffers of various pH values. Moreover, THC was more stable than curcumin in 0.1 M phosphate buffer, pH 7.2 (37 degrees C). These results, together with previous findings, suggest that curcumin-glucuronoside, dihydrocurcumin-glucuronoside, THC-glucuronoside, and THC are major metabolites of curcumin in vivo.
Similar articles
- Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP, Gescher AJ. Perkins S, et al. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):535-40. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12050094 - Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP, Gescher A. Ireson C, et al. Cancer Res. 2001 Feb 1;61(3):1058-64. Cancer Res. 2001. PMID: 11221833 - Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ. Garcea G, et al. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):120-5. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668484 Clinical Trial. - Recent studies on the biofunctions and biotransformations of curcumin.
Lin JK, Pan MH, Lin-Shiau SY. Lin JK, et al. Biofactors. 2000;13(1-4):153-8. doi: 10.1002/biof.5520130125. Biofactors. 2000. PMID: 11237176 Review.
Cited by
- Protective Role of Curcumin against N-Nitrosodiethylamine (NDEA)-Induced Toxicity in Rats.
Ali F, Rahul, Jyoti S, Fatima A, Khanam S, Naz F, Siddique YH. Ali F, et al. Sci Pharm. 2016 Apr-Jun;84(2):361-77. doi: 10.3797/scipharm.1506-06. Epub 2015 Jul 26. Sci Pharm. 2016. PMID: 27222610 Free PMC article. - Properties of lewis lung carcinoma cells surviving curcumin toxicity.
Yan D, Geusz ME, Jamasbi RJ. Yan D, et al. J Cancer. 2012;3:32-41. doi: 10.7150/jca.3659. Epub 2011 Dec 22. J Cancer. 2012. PMID: 22232696 Free PMC article. - Curcumin attenuates lupus nephritis by inhibiting neutrophil migration via PI3K/AKT/NF-κB signalling pathway.
Yang H, Zhang H, Tian L, Guo P, Liu S, Chen H, Sun L. Yang H, et al. Lupus Sci Med. 2024 Jul 24;11(2):e001220. doi: 10.1136/lupus-2024-001220. Lupus Sci Med. 2024. PMID: 39053932 Free PMC article. - A multi-targeted approach to suppress tumor-promoting inflammation.
Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis C, Boosani CS, Poudyal D, Stafforini DM, Bhakta D, Niccolai E, Guha G, Vasantha Rupasinghe HP, Fujii H, Honoki K, Mehta K, Aquilano K, Lowe L, Hofseth LJ, Ricciardiello L, Ciriolo MR, Singh N, Whelan RL, Chaturvedi R, Ashraf SS, Shantha Kumara HMC, Nowsheen S, Mohammed SI, Keith WN, Helferich WG, Yang X. Samadi AK, et al. Semin Cancer Biol. 2015 Dec;35 Suppl:S151-S184. doi: 10.1016/j.semcancer.2015.03.006. Epub 2015 May 5. Semin Cancer Biol. 2015. PMID: 25951989 Free PMC article. Review. - Colorectal cancer: chemopreventive role of curcumin and resveratrol.
Patel VB, Misra S, Patel BB, Majumdar AP. Patel VB, et al. Nutr Cancer. 2010;62(7):958-67. doi: 10.1080/01635581.2010.510259. Nutr Cancer. 2010. PMID: 20924971 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources